Web Exclusives

Cancer scan could remove need for radiotherapy in cured patients

PET scan usage for patients with early stage Hodgkin lymphoma could potentially help them avoid unneeded radiotherapy.

BRCA-targeting drug has benefit in prostate cancer

Trials results indicate that the pioneering drug olaparib, which targets inherited mutations, can be beneficial for men with prostate cancer.

New screening technique could identify ovarian cancer in twice as many women

A new screening method utilizing protein analysis can detect ovarian cancer in twice as many women as conventional strategies, according to the latest trial results.

More detailed findings confirm that coffee protects against breast cancer recurrence

More detailed findings confirm that coffee protects against breast cancer recurrence

For women with breast cancer using the drug tamoxifen, coffee appears to both inhibit tumor growth and reduce recurrence.

Cancer detection rate in dense breast tissue dramatically improved with tomosynthesis

Digital breast tomosynthesis increases the rate of cancer detection in women with dense breast tissue by as much as 67%, according to research.

Active postdischarge intervention reduces ER visits and costs in major thoracic surgery

An active, postdischarge intervention after thoracic surgery resulted in numerous benefits, including shorter hospital stays and cost savings with no increase in adverse outcomes.

Phase I trial of lung cancer drug identifies multiple types of drug resistance

Researchers urge for new targeted inhibitors and combinations to combat tumors' constant and varied molecular adaptation.

Patients with brain tumor should be screened for depression

Patients with brain tumor should be screened for depression

Depression in patients with brain cancer is easily overlooked by clinicians.

Triple-negative breast cancer is distinctly different in African American women

Triple-negative breast cancer is distinctly different in African American women

A new study reveals specific genetic alterations that appear to impact the prognosis and survival rates of African American women.

First-in-class antibody shows clinical activity against advanced colorectal cancer

Sym004, a mixture of two anti-epidermal growth factor receptor (EGFR) antibodies, was found to be clinically active in patients with advanced colorectal cancer that had become anti-EGFR therapy resistant.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs